Tricuspid valve stenosis is the rarest valvular heart disease. Most hospitals treat tricuspid valve stenosis with heart valve repair using open surgical techniques. However, there is also an alternative treatment option, namely minimally invasive balloon valvuloplasty. This treatment method is available at the leading hospitals abroad. The procedure is safely performed even on high-risk surgical patients. You are welcome to visit the Booking Health website to find the cost of treatment at foreign hospitals and select a medical care program.
Content
- What is tricuspid valve stenosis and how can it be treated?
- What is balloon dilatation?
- When can doctors use balloon dilation?
- Advantages and disadvantages of balloon dilatation
- Balloon dilatation of the bioprosthesis
- What hospitals specialize in balloon dilatation?
What is tricuspid valve stenosis and how can it be treated?
The right side of the heart has an orifice that connects the atrium to the ventricle. Blood should move through this orifice in one direction only, namely from the atrium to the ventricle. To prevent it from returning, the tricuspid valve is located in this place. It closes during the period of ventricular contraction so that the heart ejects blood into the blood vessels of the pulmonary circulation but not back into the right atrium.
This heart valve can be damaged by a pathological process, most often due to rheumatism. If the heart valve leaflets fuse together, the orifice becomes too narrow, and this condition is called stenosis. It can often be combined with valvular insufficiency, a condition in which the leaflets do not completely close the orifice, and part of the blood returns back to the right atrium when the ventricle contracts.
Tricuspid valve stenosis does not cause any symptoms in its early stages, so no treatment is provided. However, a patient is under medical supervision. If the heart defect progresses during life, surgery may be required. Indications for treatment are as follows:
- highly severe defect;
- moderately severe defect with manifested symptoms, heart arrhythmias, and progressive changes in the structure of the right chambers of the heart;
- moderately severe stenosis, if surgical treatment of other heart defects is planned.
Treatment options for tricuspid valve diseases at hospitals abroad include:
- reconstruction that involves the patient's heart valve repair;
- replacement surgery that involves the implantation of a new artificial heart valve.
Doctors at hospitals abroad always prefer heart valve repair whenever possible. This treatment approach provides the best hemodynamic parameters. In addition, only biological prostheses can be placed in the position of the tricuspid valve due to a high risk of thrombosis, but they have a short service life.
There are several options for heart valve repair depending on the mechanism of the heart valve damage, the presence of only stenosis, or its combination with valvular insufficiency. Healthcare professionals at most hospitals perform operations using open techniques through an incision in the thorax. Doctors resort to balloon valvuloplasty less commonly. This is a minimally invasive procedure through an incision in the leg that is performed from inside the blood vessels. Although this manipulation can rarely be used, some specialized hospitals abroad have sufficient experience in its application.
What is balloon dilatation?
Tricuspid valve stenosis causes a narrowing of the orifice of this heart valve, which is usually dilated with open surgery. Doctors perform a commissurotomy, an operation in which the fused leaflets of the tricuspid valve are dissected. However, if open surgery is contraindicated for a person due to the presence of concomitant diseases and a high risk of severe complications, doctors resort to a minimally invasive procedure.
Balloon dilatation is performed through an incision in the leg, and some hospitals use an incision in the arm. Doctors deliver a balloon to the heart through the blood vessels under X-ray guidance. It is inserted into the narrowed atrioventricular orifice. Doctors then inject a balloon with a contrast-enhanced saline solution, which is visible on X-ray scans. The balloon gradually expands and separates the fused heart valve leaflets.
When can doctors use balloon dilation?
Doctors at hospitals abroad rarely use balloon dilatation for treating tricuspid valve stenosis. This treatment option may be considered in the following cases:
- valve anatomy that is appropriate for balloon valvuloplasty;
- a patient has no tricuspid valve insufficiency;
- a patient has no defects in other heart valves (isolated tricuspid stenosis).
These conditions are rarely combined. This is especially true for isolated lesions of the tricuspid valve. Basically, this heart disease has a rheumatic etiology, and in rheumatism, several heart valves are usually damaged at once, including the mitral and aortic ones. However, in some cases, these heart valves can also be repaired or replaced with a prosthesis using interventional procedures. For example, in the case of aortic valve stenosis, treatment abroad is often carried out with the help of transcatheter implantation. A percutaneous method can also repair mitral stenosis or insufficiency, but not all anatomical variants of the defect can be treated with such methods.
In addition, balloon dilatation can be performed in patients with contraindications to open surgery. Sometimes this is the only possible treatment option. In this case, it is performed, ignoring all the shortcomings.
Advantages and disadvantages of balloon dilatation
As a treatment method for tricuspid stenosis, balloon dilatation has several disadvantages as compared to open surgery. For this reason, the technique is not considered a first-line treatment option.
The main disadvantages of the procedure are as follows:
- a high risk of valvular insufficiency due to excessive enlargement of the heart valve orifice;
- poor results of the procedure with heart valve leaflet calcification;
- other manipulations to repair the heart valve (strengthen the fibrous ring, close heart valve defects with patches, etc.) can not be performed simultaneously;
- healthcare professionals do not have enough scientific data on the long-term results of the procedure since the world experience with its implementation is relatively small (tricuspid stenosis is very rare, and balloon dilatation is not the first-line treatment).
At the same time, the procedure has many advantages. It is less likely to cause complications as compared to open surgery. The manipulation is minimally traumatic, does not require any rehabilitation, and the duration of a hospital stay is minimal. The procedure can be safely performed even in those patients who, due to their poor health, have contraindications for open surgery.
Balloon dilatation of the bioprosthesis
Patients with tricuspid valve defects undergo not only operations and interventional procedures to repair them but also replacement surgery. Moreover, only biological prostheses can be implanted in the position of the tricuspid valve since the mechanical ones are associated with a high risk of blood clots, even when taking anticoagulants.
Biological prostheses on the right side of the heart serve longer than on the left one. However, sooner or later, they will be damaged, and one of the reasons for bioprosthesis dysfunction may be its stenosis.
The main treatment option for these patients is revision replacement surgery. Doctors perform surgery to implant a new heart valve.
This operation is, however, traumatic, and at the time of admission, many patients have weakened conditions and are not able to undergo open heart surgery. In this case, doctors may use balloon dilatation of an artificial tricuspid valve as a palliative procedure. This treatment approach does not provide any long-term therapeutic results due to the early repeated implant stenosis. However, balloon dilatation allows an improvement in hemodynamics for 4-6 months. During this time, doctors can stabilize the patient's condition and prepare him for open surgery, namely the revision replacement procedure.
What hospitals specialize in balloon dilatation?
You can undergo your treatment in Germany or at hospitals in other developed countries. You are welcome to visit the Booking Health website, which offers the best hospitals in the world and specifies the cost of treatment for heart valve defects in each of them. If you cannot decide on a choice, please leave your request on our website. The specialists from the Booking Health company will contact you by phone within the next few hours and help you to select a hospital in Germany that specializes in the treatment of heart valve disease and has vast experience in performing balloon dilatation for tricuspid valve stenosis.
There are a few reasons for you to undergo your treatment at hospitals in Germany or other developed countries:
- specialized hospitals have vast experience in treating tricuspid valve stenosis, which is a rare heart disease, so most doctors in the world do not often deal with its management;
- state-of-the-art equipment that is available at the hospitals allows specialists to carry out the interventional procedure efficiently and safely;
- there is a low risk of complications, including tricuspid valve insufficiency;
- a high rate of successful procedures;
- good long-term results;
- doctors at hospitals in Germany can repair several heart valve defects at once using interventional methods, for example, tricuspid valve balloon dilatation and transcatheter aortic valve implantation.
You can make your appointment for balloon valvuloplasty at hospitals in Germany through the Booking Health service. In this case, the cost of treatment will be lower and our specialists will fully arrange your trip to a hospital abroad.
Authors:
The article was edited by medical experts, board-certified doctors Dr. Nadezhda Ivanisova and Dr. Vadim Zhiliuk. For the treatment of the conditions referred to in the article, you must consult a doctor; the information in the article is not intended for self-medication!
Sources:
European Society of Cardiology
American College of Cardiology
PubMed